Excessive intake of sugar: An accomplice of inflammation
X Ma, F Nan, H Liang, P Shu, X Fan, X Song… - Frontiers in …, 2022 - frontiersin.org
High sugar intake has long been recognized as a potential environmental risk factor for
increased incidence of many non-communicable diseases, including obesity, cardiovascular …
increased incidence of many non-communicable diseases, including obesity, cardiovascular …
Fructose and sugar: A major mediator of non-alcoholic fatty liver disease
T Jensen, MF Abdelmalek, S Sullivan, KJ Nadeau… - Journal of …, 2018 - Elsevier
Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic
syndrome; its rising prevalence parallels the rise in obesity and diabetes. Historically …
syndrome; its rising prevalence parallels the rise in obesity and diabetes. Historically …
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
ME Rinella, BA Neuschwander-Tetri, MS Siddiqui… - Hepatology, 2023 - journals.lww.com
Abbreviations: AASLD, American Association for the Study of Liver Diseases; AI, artificial
intelligence; ALT, alanine aminotransferase; AST, aspartate aminotransferase; AUROC …
intelligence; ALT, alanine aminotransferase; AST, aspartate aminotransferase; AUROC …
The small intestine converts dietary fructose into glucose and organic acids
Excessive consumption of sweets is a risk factor for metabolic syndrome. A major chemical
feature of sweets is fructose. Despite strong ties between fructose and disease, the …
feature of sweets is fructose. Despite strong ties between fructose and disease, the …
The role of the gut microbiota in NAFLD
C Leung, L Rivera, JB Furness… - … reviews Gastroenterology & …, 2016 - nature.com
NAFLD is now the most common cause of liver disease in Western countries. This Review
explores the links between NAFLD, the metabolic syndrome, dysbiosis, poor diet and gut …
explores the links between NAFLD, the metabolic syndrome, dysbiosis, poor diet and gut …
Prebiotic inulin and sodium butyrate attenuate obesity-induced intestinal barrier dysfunction by induction of antimicrobial peptides
J Beisner, L Filipe Rosa, V Kaden-Volynets… - Frontiers in …, 2021 - frontiersin.org
Defects in the mucosal barrier have been associated with metabolic diseases such as
obesity and non-alcoholic fatty liver disease (NAFLD). Mice fed a Western-style diet (WSD) …
obesity and non-alcoholic fatty liver disease (NAFLD). Mice fed a Western-style diet (WSD) …
Role of dietary fructose and hepatic de novo lipogenesis in fatty liver disease
Nonalcoholic fatty liver disease (NAFLD) is a liver manifestation of metabolic syndrome.
Overconsumption of high-fat diet (HFD) and increased intake of sugar-sweetened …
Overconsumption of high-fat diet (HFD) and increased intake of sugar-sweetened …
Animal models of nonalcoholic fatty liver disease—a starter's guide
MA Van Herck, L Vonghia, SM Francque - Nutrients, 2017 - mdpi.com
Nonalcoholic fatty liver disease (NAFLD) constitutes a major health concern with the
increasing incidence of obesity and diabetes in many Western countries, reaching a …
increasing incidence of obesity and diabetes in many Western countries, reaching a …
Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signaling
Overconsumption of high-fat diet (HFD) and sugar-sweetened beverages are risk factors for
developing obesity, insulin resistance, and fatty liver disease. Here we have dissected …
developing obesity, insulin resistance, and fatty liver disease. Here we have dissected …
Hepatocyte TAZ/WWTR1 promotes inflammation and fibrosis in nonalcoholic steatohepatitis
Nonalcoholic steatohepatitis (NASH) is a leading cause of liver disease worldwide.
However, the molecular basis of how benign steatosis progresses to NASH is incompletely …
However, the molecular basis of how benign steatosis progresses to NASH is incompletely …